Live GMAT classes with Target Test Prep start Nov 21 and Nov 22. First class free.

See classes
Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

★★★★★5.0563 reviews
GMATLiveTeachStarts Nov 22
Josh Braslow, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Josh Braslow, 20+ years in test prep

Nov 22 · Josh Braslow
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemandStart anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

EXECUTIVE ASSESSMENT

with

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemandStart anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Emergence of biotechnology companies

Expert replies
by sk8ternite » Sun Jul 05, 2009 4:33 pm
With the emergence of biotechnology companies, it was feared that they would impose silence about proprietary results on their in-house reseachers and their academic consultants. This constraint, in turn, would slow the development of biological science and engineering.

Which of the following, if true, would tend to weaken most seriously the prediction of scientific secrecy described above?

(a) Biotechnological research funded by industry has reached some conclusions that are of major scientific importance.
(b) When the results of scientific research are kept secret, independent researchers are unable to build on those results.
(c) Since the research priorities of biotechnology companies are not the same as those of academic institutions, the financial support of research by such companies distorts the research agenda.
(d) To enhance the companies' standing in the scientific community, the biotechnology companies encourage employees to publish their results, especially results that are important.
(e) Biotechnology companies devote some of their research resources to problems that are of fundamental scientific importance and that are not expected to produce immediate practical applications.

Please provide an answer and reasoning...[/spoiler]
Join the discussion
Source: — Critical Reasoning |

by Domnu » Wed Jul 08, 2009 3:05 pm
The answer should be D, since [spoiler]publishing doesn't really preserve secrecy.[/spoiler]
Have you wondered how you could have found such a treasure? -T
Join the discussion

by mehravikas » Wed Jul 08, 2009 4:41 pm
Option 'D' is the best choice. D clearly states that to enhance companies' biotechnology companies encourage employees to publish their results. So those companies would never impose silence about the proprietary results...
Join the discussion

by james33 » Sun May 15, 2016 8:31 pm
I agree with you guys. I also think that the right answer is D
Join the discussion